# Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection

> **NCT02170246** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 21 (actual)

## Conditions studied

- Acute HIV Infection
- HIV Infections

## Interventions

- **DRUG:** Telmisartan

## Key facts

- **NCT ID:** NCT02170246
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-28
- **Primary completion:** 2018-06-13
- **Final completion:** 2018-06-13
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2020-03-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02170246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02170246, "Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02170246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*